A Novel Protein Structure ‘SHOC2-MRAS-PP1C (SMP) Complex’ Offers ways to Target RAS-Pathway Proteins in Cancer
A significant complex of RAS-pathway proteins’ structure has been determined by scientists, revealing how known disease-causing mutations result in illness and offering prospective novel binding sites for cancer drugs. One of the most well-known causes of cancer is RAS gene mutations, which result in tumor formation in about 25% of cancer patients. Broad Institute of…
